Wikisage, the free encyclopedia of the second generation, is digital heritage
Zonisamide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug. | zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug. | ||
It inhibitory action against carbonic anhydrase coul be related with perception of taste, and the novo lipogenesis. | |||
It inhibitory action | |||
<ref> | <ref> | ||
[http://ac.els-cdn.com/S071686401270295X/1-s2.0-S071686401270295X-main.pdf?_tid=015b25bc-89ef-11e7-8ccc-00000aacb35d&acdnat=1503704707_e514043afaffa54860aa6f4fa522df67 Tratamiento farmacológico de la obesidad Pharmacological obesity treatment]</ref> | [http://ac.els-cdn.com/S071686401270295X/1-s2.0-S071686401270295X-main.pdf?_tid=015b25bc-89ef-11e7-8ccc-00000aacb35d&acdnat=1503704707_e514043afaffa54860aa6f4fa522df67 Tratamiento farmacológico de la obesidad Pharmacological obesity treatment]</ref> | ||
| Line 10: | Line 9: | ||
<references/> | <references/> | ||
{{wikidata|Q219957}} | |||
Revision as of 23:52, 25 August 2017
zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug.
It inhibitory action against carbonic anhydrase coul be related with perception of taste, and the novo lipogenesis. [1] Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity
